Drug intelligence / Profile preview

Zebiforte

Development stage: Unknown
Lead developer: Resilient Cosmeceuticals
Modality: Small Molecules
Administration: Oral

Overview

Zebiforte is a high-potency multivitamin and multimineral supplement developed by Resilient Cosmeceuticals. It is formulated as an oral tablet containing a comprehensive blend of B-complex vitamins (B1, B2, B3, B5, B6, B7, B9, and B12), Vitamin C (ascorbic acid), and Zinc. The supplement is indicated for the management of nutritional deficiencies associated with fever, fatigue, physical and mental stress, and during convalescence following illness or surgery. The B-vitamins serve as essential cofactors in cellular energy production and neurological function, while Vitamin C and Zinc provide antioxidant support and enhance immune system performance.

Brand names: Zebiforte
Other names: Zebiforte Tablet

Beyond the preview

Go deeper on Zebiforte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zebiforte.

Explore the full profile